0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-87.97%PremiumNov 15, 2024Expiry Date1.17Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.86Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Biodesix Stock Discussion
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
Biodesix (Nasdaq: BDSX) announced new data presentation at CHEST 2024 Annual Meeting and launch of a complementary clinical study. The presentation will showcase the use of Nodify Lung® Nodule Risk Assessment in over 35,000 patients in real-world settings. Dr. Kathryn Long will present findings on reclassification rates for lung cancer risk, highlightin...
In reaction to earnings/guidance:
• $Omnicom Group (OMC.US)$ +6.8% (Omnicom reports Q2 EPS $1.68, consensus $1.58)
• $Netflix (NFLX.US)$+6.3% (Netflix executives said they expect 1 million new subscribers to join in the third quarter, with revenue forecast to grow to $7.84 billion from $7.48 billion a year ago)
• $Fulton Financial (FULT.US)$ +4.3% (Fulton Financial reports Q2 EPS 42c, consensus 37c)
• $Abbott Laboratories (ABT.US)$ +0.6% (Ab...
small float on market watch, is this a squeeze play? The chart has a lot of promise
No comment yet